Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations

Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease

(2010) Mutsumi Iijima et al.   MOVEMENT DISORDERS

LRRK2 and neurodegeneration

(2009) Gabriel Santpere et al.   ACTA NEUROPATHOLOGICA

Validation of cardiac 123I-MIBG scintigraphy in patients with Parkinson’s disease who were diagnosed with dopamine PET

(2009) Kenji Ishibashi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Neuropathology of Parkinson's disease with the R1441G mutation inLRRK2

(2009) José-Félix Martí-Massó et al.   MOVEMENT DISORDERS

The scientific and clinical basis for the treatment of Parkinson disease (2009)

(2009) C. W. Olanow et al.   NEUROLOGY

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

(2008) Daniel G Healy et al.   LANCET NEUROLOGY

LRRK2 G2019S and R1441G mutations associated with Parkinson’s disease are common in the Basque Country, but relative prevalence is determined by ethnicity

(2008) A. Gorostidi et al.   NEUROGENETICS

Hyposmia in G2019S LRRK2-related parkinsonism: Clinical and pathologic data

(2008) L. Silveira-Moriyama et al.   NEUROLOGY

Association of olfactory dysfunction with risk for future Parkinson's disease

(2007) G. Webster Ross et al.   ANNALS OF NEUROLOGY

Myocardial123metaiodobenzylguanidine uptake in genetic Parkinson's disease

(2007) Aldo Quattrone et al.   MOVEMENT DISORDERS